![Zorbtive [somatropin (rDNA origin) for injection]](images/Zorbtive_180.png)
How SeroCareSM
can help Zorbtive patients
Helpful information for people with SBS considering Zorbtive treatment
Clinical information about Zorbtive for health professionals
Clinical opinions about Zorbtive and goals of treatment for Short Bowel Syndrome
|
This information is available to health professionals who treat people with Short Bowel Syndrome.
A Treatment Guideline for Zorbtive (right), and A Clinical Review for Zorbtive are available to health professionals by completing a simple Clinical Information Request Form.
A journal article from Annals of Surgery (2005) containing Zorbtive pivotal trial data is also available.
The information you request will be mailed to your office, and a readable, printable PDF will be sent to your e-mail. (Note: the Annals of Surgery article is available only in printed form, not as a PDF.)
A Statement of Medical Necessity (SMN) form can also be found here as a printable PDF. If you are a health professional and wish to view or print the SMN form, click on the underlined text above or the image at right.
Health professionals are also welcome to call SeroCareSM toll free at 800-714-2437 for information and answers to questions.
How SeroCareSM can help
Zorbtive patients
Helpful information for people with SBS, considering
Zorbtive treatment
Clinical information about Zorbtive for health
professionals
Clinical opinions about Zorbtive and goals
of treatment for Short Bowel Syndrome
Glossary
Links
Home
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.
Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).
Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.
Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.
This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCareSM
toll free at 800-714-2437. Zorbtive is available by prescription only.
This Web site was developed by EMD
Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS
patients
and interested healthcare professionals about this treatment for Short Bowel
Syndrome. Zorbtive is exclusively marketed by
Emmaus Medical, Inc. (emmausmedical.com),
Tel: 1-877-420-6493.
This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.
© 2007 EMD Serono, Inc. All rights reserved. 